机会性疾病和合并感染-HIV-Clinical Care Options Chinese

CCO.Feature.Widgets.LiveEvents.FindEventsNearMe

HIV-ASSIST: A Patient-Centered, Evidence-Based Tool for ART Selection 3 CCO.Feature.Widgets.LiveEvents.UpcomingEvents 6/15/2021 了解更多

Contemporary Management of HIV 2021 2 CCO.Feature.Widgets.LiveEvents.UpcomingEvents 5/12/2021 了解更多

CCO.Feature.Widgets.InPractice.Tagline

HIVCCO.Feature.Widgets.InPractice.LatestNewsTitle

New data and guidance from the DHHS on the use of dolutegravir during conception and at all stages of pregnancy

FDA approval of fostemsavir for use in combination with other ARV agents in heavily treatment–experienced patients with multidrug-resistant HIV

Data from the BRIGHTE trial evaluating fostemsavir in heavily treatment–experienced adults with multidrug-resistant HIV infection

Data from study 4030 of switching patients on a stable dolutegravir-based regimen to bictegravir

CCO.Feature.Widgets.InPractice.MoreLinkTitle